HIBT Lab! Immunai: Noam Solomon

Laura Modi set out to build a better infant formula. What followed was years of setbacks: a crippling dispute with the FDA, a frustrating search for a manufacturer, and the constant fear that the company would run out of money before it reached customers.But today, Bobbie generat ...  Show more

Today's callers: Bob in Chicago looks to promote his cabbage-based muscle and joint rub beyond the walls of his orthopedic practice. Then Abby in Dallas wonders whether her popular social media livestreams are a sustainable way to market her trendy phone cases. And Henry in Charl ...  Show more

What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ...  Show more

It’s widely assumed that drug treatment is a miracle of modern science. However, it’s equally arguable that modern drug treatment is a very expensive disaster, with serious consequences for public health. For example, a drug typically takes 10-12 years to develop and the cost is ...  Show more

It can take 15 years to get one life-saving drug to market. Cutting-edge scientists are finding new ways to shift through unimaginable quantities of data faster than ever before. -- This program is produced by Mission.org and brought to you by Splunk, the Data-to-Everything Platf ...  Show more

In this episode, we’re joined by Noam Baumatz, CEO and Co-Founder of Noga Therapeutics, a company dedicated to developing gene therapies for rare and severe diseases through engineering macrophages. Motivated by his highly personal experience of rare disease, Noam founded Noga to ...  Show more